Abstract
Introduction

36
Due to widespread antimicrobial resistance (AMR) in Neisseria gonorrhoeae, a bacterial 37 pathogen of global priority (1), the management and control of gonococcal infection remain 38 problematic. N. gonorrhoeae resistance has developed over the past 70 years since the advent of 39 antibiotics, and resistance to penicillins, tetracyclines and fluoroquinolones successively 40 emerged following the introduction of these antimicrobials into clinical practice (2). The rapid 41 decrease in antimicrobial susceptibility of N. gonorrhoeae to macrolides (azithromycin), 42 aminocyclitols (spectinomycin), and especially extended-spectrum cephalosporins is an 43 important modern public health problem associated with the risk of untreatable gonorrhea (3).
44
The notable ability of N. gonorrhoeae to develop AMR is determined by the acquisition of resistance to penicillins through the acquisition of beta-lactamase activity (6). Resistance to 50 tetracyclines involves V57M or V57L amino acid substitutions in ribosomal protein S10 (the 51 rpsJ gene product) (7) and the plasmid-mediated tetM determinant (8). Resistance to 52 fluoroquinolones is caused by mutations in the gyrA and parC genes encoding the gyrase and 53 topoisomerase proteins that form a "quinolone pocket" (QRNG region) (9). Acquired resistance 54 to spectinomycin and azithromycin is determined by mutation of the rrs (16S RNA) and rrl (23S Furthermore, resistance to ciprofloxacin was detected in 83 of the 268 isolates (31%), whereas Table 1 .
248
In the isolates included in the study in 2005, the D345A insertion in the penA gene was the most 249 predominant determinant, followed by the ponA L421P mutation. Double mutations in these loci distribution. However, the proportion of isolates harboring the bla TEM plasmid-borne gene did not 257 significantly change, and these isolates were highly resistant to penicillin G.
258
Concerning the tetracycline-resistant isolates, the V57M substitution in the rpsJ gene was the Among the 2005 isolates, the A2059G mutation in the rrl gene responsible for resistance to 275 macrolides and the rrs С1192Т mutation associated with aminocyclitol resistance were detected 276 sporadically in 3 and 2 isolates (0.7% and 0.5%), respectively. However, in 2016, these AMR 277 determinants were not found.
278
Finally, we analyzed mutations in the porB1b and mtrR genes that led to reduced susceptibility we report the decreasing trend in AMR to agents used in traditional gonorrhea treatment 300 (penicillin G, tetracycline and ciprofloxacin), which had been extremely high in previous years. 
313
Emerging resistance to spectinomycin was described during the study period, with maximum 314 resistance noted in 2011. To prevent further increases in resistance to this important 315 antimicrobial, spectinomycin was recommended for alternative gonorrhea treatment only in 316 regions with proven N. gonorrhoeae susceptibility. As shown by the current results, this crisis 317 has been overcome, and susceptibility to spectinomycin recovered to a minimum of 95%.
Indeed, in 2016, we found no mutation profiles in the rrs gene that determine high-level 319 resistance to this antimicrobial.
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Similar dynamics were found for azithromycin resistance, although complete reversion did not 321 occur, and these changes cannot be explained by national guideline revisions.
322
During the study period, only a few N. gonorrhoeae isolates resistant to ceftriaxone were 
